Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

PFIZER INC
Mes dernières consult.
Most popular
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on PFIZER INC
02:13a PFIZER : granted patent on pneumonia vaccine, blow to aid group
08/23 PFIZER : Blumenthal calls on the ftc to protect consumers from drug shortages
08/23 PFIZER : BESPONSA - Approved for Treatment of Adult Relapsed or Refractory B-cel..
08/23 PFIZER INC. : - Alliance Foundation Trials Opens Global Trial Investigating Firs..
08/23 PFIZER : BESPONSA (inotuzumab Ozogamicin) Approved for Treatment of Adult Relaps..
08/22 VISTAGEN THERAPEUTICS : Expands VistaStem`s Scientific Advisory Board with Appoi..
08/22 PFIZER : Alliance Foundation Trials Opens Global Trial Investigating First-in-Cl..
08/22 PFIZER : objects to NICE methods in leukaemia drug rejection
08/22 PFIZER : Malaysia brings healthcare to remote Sabah villages
08/22 PFIZER : Pfizers Besponsa gets FDA approval for treatment of B-cell precursor AL..
08/22 PFIZER : NICE set to reject Pfizer`s leukaemia drug Besponsa
08/22 PFIZER : Bristol-Myers Squibb and Pfizer to Highlight Commitment to Reducing the..
08/21 PFIZER : Health and Human Services Department (HHS); Food and Drug Administratio..
08/21 BRISTOL MYERS SQUIBB : and Pfizer to Highlight Commitment to Reducing the Risk o..
08/21 PFIZER : s Besponsa Is Yet Another Win for the Biopharma Giant
08/19 PFIZER : future
08/19 PFIZER : locks down US approval for Besponsa
08/19 PFIZER : Thomas Wynn makes the leap out of the NIH and into a lead discovery pos..
08/19 PFIZER : U.S. pharmaceutical firms to extend investments in Egypt
08/18 PFIZER : Global Anal Fistula Treatment Market 2022 - Teva, Novartis, Pfizer, Roc..
08/18 PFIZER : Bristol-Myers Squibb and Pfizer to Highlight Commitment to Reducing the..
08/18 PFIZER : Receives U.S. FDA Approval F=for Besponsa (Inotuzumab Ozogamicin)
08/18 BRISTOL-MYERS SQUIBB AND PFIZER : to Highlight Commitment to Reducing the Risk o..
08/18 PFIZER : Receives u.s. fda approval for besponsa
08/17 PFIZER : FDA OKs Pfizer drug for rare, fast-killing type of leukemia
08/17 PFIZER : Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin)
08/17 FINDINGS FROM PFIZER IN PHARMACOLOGY : Clinical Pharmacology Perspectives)
08/17 PFIZER : Lessening the Burden of Non-Communicable Diseases
08/17 PFIZER : Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin)
08/17 PFIZER : Patent Application Titled "Sildenafil Sublingual Spray Formulations" Pu..
08/17 PFIZER : Avara Pharmaceutical Services acquires Sterile facility from Pfizer in ..
08/17 PFIZER : Researchers Submit Patent Application, "Dual-Ended Lip Balm Container",..
08/17 PFIZER : "Dual-Ended Lip Balm Container" in Patent Application Approval Process ..
08/17 PFIZER : FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical..
08/17 PFIZER : Investigators at Pfizer Report Findings in Rheumatoid Arthritis (Estima..
08/17 PFIZER : Research from Pfizer Reveals New Findings on Pain (Visceral and somatic..
08/17 PFIZER : to expand in Sanford for gene-therapy medications
08/17 Chinas HitGen bags new drug discovery deal with Aduro
08/16 PFIZER : Supports the UN Global Goals for Sustainable Development
08/14 PFIZER : A Holistic Approach to Empowering Health Entrepreneurs
08/14 PFIZER : Health and Human Services Department (HHS); Food and Drug Administratio..
08/14 US pharma giant targets heart disease at county level
08/11 PFIZER : attempting to develop therapies for pancreatic cancer have failed
08/11 PFIZER : Skin toxicity mechanisms associated with mGluR5 negative allosteric mod..
08/11 PFIZER : Protalix BioTherapeutics Reports 2017 Second Quarter Results and Provid..
08/11 PFIZER : Shares Sold by United Bank Inc.
08/11 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. ..
08/10 ICU MEDICAL, INC. (NASDAQ : ICUI) Files An 8-K Financial Statements and Exhibits
08/10 PFIZER : Management's Discussion and Analysis of Financial Condition and Results..
08/10 PFIZER : Trademark Application for "PFIZER INJECTABLES" Filed by Pfizer
08/10 PFIZER : Data on Psoriasis Reported by Researchers at Pfizer (Effectiveness of L..
08/10 PFIZER : Data on Type 2 Diabetes Discussed by Researchers at Pfizer (Transporter..
08/10 PFIZER : FDA Advisory Committee Votes in Favor of XELJANZ® tofacitinib citrate f..
08/10 PFIZER : Data from Pfizer Provide New Insights into Medicinal Chemistry (Applica..
08/10 PFIZER : Fake cancer drugs sold on Ugandan market
08/10 PFIZER : Fake cancer drugs hit Uganda market
08/09 PFIZER : $100 million expansion and only 40 jobs?
08/09 ACLARIS THERAPEUTICS : Acquires Confluence Life Sciences, Inc.
08/09 EARNINGS REVIEW AND FREE RESEARCH RE : Johnson Controls’ Adjusted Net Inco..
08/09 ACLARIS THERAPEUTICS : Acquires Confluence Life Sciences, Inc
08/09 PFIZER : Aclaris bags St. Louis biotech for $20M; Pfizer investing $100M in gene..
08/08 PFIZER : to Invest in Gene Therapy Manufacturing Facility in North Carolina
08/08 PFIZER : bringing 40 high-paying jobs to Sanford
08/07 PFIZER : Health and Human Services Department (HHS); Food and Drug Administratio..
08/05 PFIZER : Biosimilar boost for Pfizer but Inflectra takes just 2.3% of US inflixi..
08/04 THE PFIZER FOUNDATION : Reaching Individuals in Need
08/04 PFIZER : FDA Advisory Committee Votes in Favor of Xeljanz (Tofacitinib Citrate) ..
08/04 BELLICUM PHARMACEUTICALS : Appoints Gregory Naeve as Chief Business Officer
08/04 PFIZER : Fda advisory committee votes in favor of xeljanz for the treatment of a..
08/04 PFIZER : FDA Advisory Committee Votes in Favor of XELJANZ® (tofacitinib citrate)..
08/04 STANDARD OF REVIEW : A New Character Does Not Give ‘Suits’ The Boost..
08/04 SANOFI : Judicial Panel on Multidistrict Litigation Issues Order on Epipen
08/03 PFIZER : FDA Advisory Committee Votes in Favor of XELJANZ® (tofacitinib citrate)..
08/03 PFIZER : Report Summarizes Type 2 Diabetes Study Findings from Pfizer (Once-week..
08/03 PFIZER : Reports Findings in Life Science Research (Detecting expression of 5T4 ..
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2017 52 724 M
EBIT 2017 19 846 M
Net income 2017 11 415 M
Debt 2017 23 771 M
Yield 2017 3,86%
P/E ratio 2017 17,72
P/E ratio 2018 15,36
EV / Sales 2017 4,21x
EV / Sales 2018 4,04x
Capitalization 198 B
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 37,5 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
W. Don Cornwell Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER INC197 948
JOHNSON & JOHNSON15.83%361 535
NOVARTIS7.89%219 476
ROCHE HOLDING LTD.3.78%218 387
PFIZER2.06%197 412
MERCK AND COMPANY6.03%170 241